The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
The Registry to Observe Clinical Outcomes of Patients With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
The purpose of this registry study is to longitudinally observe clinical outcomes and patient-reported outcomes (PRO) for participants with high-risk metastatic hormone-naive prostate cancer (mHNPC) in the real-world setting in Japan.
Inclusion Criteria:
Exclusion Criteria:
- has any other active malignancies
Hakata-Ku, 812-0033, Japan
Itabashi Ku, 173 8606, Japan
Kahoku-District, 920-0293, Japan
Kamigyo, 602-8566, Japan
Kisarazu-shi, 292-8535, Japan
Kita Gun, 761 0793, Japan
Nakagami Gun, 903-0215, Japan
Osaka Sayama Shi, 589 8511, Japan
Shinjuku-ku, Japan
Suita-shi, 565-0871, Japan
Toon-shi, 791-0295, Japan